Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02064959 · ClinicalTrials.gov registry record · NA
To Study the Effect of Early Cooling in Acute Subdural Hematoma Patients
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02064959 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 32 participants.
The verdict
NCT02064959, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This randomized, prospective trial will study the effect of very early cooling in patients undergoing surgical evacuation of acute subdural hematomas (35°C prior to opening the dura followed by maintenance at 33°C for a minimum of 48h). Intravascular cooling catheters (Thermogard XP Device, Zoll) will be utilized to induce hypothermia or to maintain normothermia. The primary objective is to determine if rapid induction of hypothermia prior to emergent craniotomy for traumatic subdural hematoma (SDH) will improve outcome as measured by Glasgow Outcome Scale-Extended (GOSE) at 6 months.
Interventions
- DEVICE Temperature management Zoll Intravascular Temperature Management device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-03-22 |
| Est. Completion | 2019-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02064959
The ClinicalTrials.gov registry entry for NCT02064959 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Temperature management Zoll Intravascular Temperature Management device is the first listed.
NCT02064959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02064959 about?
NCT02064959 is a clinical study titled "To Study the Effect of Early Cooling in Acute Subdural Hematoma Patients". This randomized, prospective trial will study the effect of very early cooling in patients undergoing surgical evacuation of acute subdural hematomas (35°C prior to opening the dura followed by maintenance at 33°C for a minimum of 48h). Intravascular cooling catheters (Thermogard XP Device, Zoll) wi...
What is the current status of trial NCT02064959?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2014-03-22. Estimated completion is 2019-02-07.
What interventions are being tested in trial NCT02064959?
The interventions under investigation include: Temperature management Zoll Intravascular Temperature Management device (DEVICE).
Who is sponsoring clinical trial NCT02064959?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.